Entrada Therapeutics Inc. (TRDA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Entrada Therapeutics Inc.

    NASDAQ: TRDA · Real-Time Price · USD
    5.96
    0.04 (0.68%)
    At close: Oct 03, 2025, 3:19 PM

    Entrada Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 9.83 -74.6 -4.84 -10.68
    PEG Ratio
    		 -0.01 0.80 -0.07 -0.12
    PS Ratio
    		 3.06 3.87 n/a n/a
    PB Ratio
    		 1.50 2.06 1.99 1.79
    P/FCF Ratio
    		 -14.43 3.72 -4.38 -9.64
    P/OCF Ratio
    		 -15.52 3.57 -4.51 -10.51
    OCF/S Ratio
    		 -0.2 1.08 n/a n/a
    Debt / Equity Ratio
    		 0.14 0.28 0.12 n/a
    Quick Ratio
    		 11.15 2.33 9.55 44.46
    Current Ratio
    		 11.15 2.33 9.55 44.46
    Asset Turnover
    		 0.40 0.27 n/a n/a
    Interest Coverage
    		 n/a n/a -36.95 n/a
    Return on Equity
    		 0.15 -0.03 -0.41 -0.17
    Return on Assets
    		 0.12 -0.01 -0.35 -0.16
    Return on Invested Capital
    		 0.09 0.01 -0.36 -0.17
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 0.23 n/a n/a
    Net Profit Margin
    		 0.31 -0.05 n/a n/a
    Pretax Profit Margin
    		 0.32 0.09 n/a n/a
    Operating Profit Margin
    		 0.22 -0.02 n/a n/a
    FCF Margin
    		 -0.21 1.04 n/a n/a
    EBITDA Margin
    		 0.22 -0.00 n/a n/a

    Add to Watchlist